Login / Signup

Novel Oncogenic <i>PDGFRB</i> Variant in Severe Infantile Myofibromatosis With Response to Imatinib Using Therapeutic Drug Monitoring.

Abbey ElsberndBoutaina BoulouadnineAtif A AhmedMidhat S FarooqiTracy SandritterValentina ShakhnovichDarius BlandingJean-Baptiste DemoulinJoel Thompson
Published in: JCO precision oncology (2022)
Keyphrases
  • chronic myeloid leukemia
  • early onset
  • transcription factor
  • drug induced